U.S. markets open in 4 hours 28 minutes
  • S&P Futures

    4,554.25
    +9.75 (+0.21%)
     
  • Dow Futures

    35,431.00
    +42.00 (+0.12%)
     
  • Nasdaq Futures

    15,658.75
    +71.50 (+0.46%)
     
  • Russell 2000 Futures

    2,254.30
    +4.80 (+0.21%)
     
  • Crude Oil

    82.21
    -0.45 (-0.54%)
     
  • Gold

    1,803.20
    +4.40 (+0.24%)
     
  • Silver

    24.16
    -0.04 (-0.15%)
     
  • EUR/USD

    1.1597
    -0.0009 (-0.08%)
     
  • 10-Yr Bond

    1.5290
    0.0000 (0.00%)
     
  • Vix

    16.88
    +0.90 (+5.63%)
     
  • GBP/USD

    1.3754
    +0.0012 (+0.09%)
     
  • USD/JPY

    113.6190
    -0.1910 (-0.17%)
     
  • BTC-USD

    60,671.31
    +1,503.19 (+2.54%)
     
  • CMC Crypto 200

    1,465.45
    -8.88 (-0.60%)
     
  • FTSE 100

    7,235.90
    -17.37 (-0.24%)
     
  • Nikkei 225

    28,820.09
    -278.15 (-0.96%)
     

Could AbbVie's New Collaboration Be a Blockbuster?

·5 min read
Could AbbVie's New Collaboration Be a Blockbuster?
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

AbbVie recently announced a strategic partnership with Regenxbio for wet age-related macular degeneration and diabetic retinopathy treatment.